SABS icon

SAB Biotherapeutics

39 hedge funds and large institutions have $1.71M invested in SAB Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$355K
2
$309K
3
$223K
4
$132K
5
$122K
6
$78.2K
7
$65.9K
8
$59.2K
9
$48.4K
10
$37K
11
$35.7K
12
$32K
13
$30K
14
$23K
15
$20.9K
16
$19.6K
17
$16.8K
18
$12.5K
19
$10.1K
20
$8.4K
21
$7.61K
22
$7.14K
23
$7K
24
$7K
25
$6.61K